Hyderabad, Oct 9: Telugu Desam Party (TDP) will today announce a pro-Telangana stand to pave way for an alliance with Telangana Rashtra Samithi (TRS) in the next year''s elections, reversing its traditional position opposing bifurcation of Andhra Pradesh.
On Tuesday, at a meeting of the Politburo, chaired by party chief N. Chandrababu Naidu in Hyderabad, the issue was discussed and a decision was taken to make the announcement on October 9, coinciding with "Vijaya Dashami" festival, according to reports.
The four-day test match against Australians at The Rajiv Gandhi Stadium, Hyderabad was a feast for the eyes and soul. Although, the Board President's XI started with a quick loss of three wickets, they soon regained position with the Mumbai youngster Rohit Sharma, who not only scored a magnificent 105 runs but also guarded the pitch, helping XI Team reach safe grounds.
Berlin/Hyderabad, Oct 1 : Infotech Enterprises Limited signed with Bombardier Transportation a new long term contract to continue to provide engineering, electronic design, technical publications and IT-related services to Bombardier Transportation divisions worldwide.
The contract builds on a relationship that started in 2003 and now Infotech supports all Bombardier divisions across multiple technologies and projects in a real-time engineering environment.
Hyderabad, Sept. 30: One of India's prominent Muslim leaders and Majlis-e-Ittehadul Muslimeen (MIM) president Sultan Salahuddin Owaisi died here on Monday night after a prolonged illness. He was 76.
Owaisi was admitted to a private hospital on September 13 with breathing problems and had been on a ventilator since then. He breathed his last at around 9 p. m. at his residence in Hyderguda, a few hours after he was shifted from hospital, his son and Hyderabad MP Asaduddin Owaisi said.
He is survived by his wife, three sons and a daughter.
Hyderabad-based Aurobindo Pharma has informed that it has secured approval from US Food and Drug Administration (USFDA) for marketing Cyclobenzaprine hydrochloride tablets.
Under the approval, the company will market and distribute the drug in 10 mg and 5 mg strengths. The drug is a muscle relaxant, which is prescribed to relieve muscle spasms resulting from injuries such as sprains, strains, or pulls.